In addition to the annual iSpot monthly pharma TV ad rankings, Tubular Labs provides an insight into how pharma brands are ...
Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...
Government-funded academic research on parallel computing, stream processing, real-time shading languages, and programmable ...
Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease ...
Indian Defence Review on MSN
They Are Moving the Rivers of an Entire Province to Protect Lakes, Fish, and an Ecosystem Running Out of Time
The province is tearing into its own rivers. Not to dam them. Not to drain them. But to fix a problem decades in the making ...
Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
Eastern Virginia's SWIFT initiative addresses groundwater depletion by treating wastewater to recharge the Potomac Aquifer, ...
Explore the Unbuilt Award 2026, which offers a €100,000 prize fund, and discover the winners of the competition's 2025 ...
From a 412-horsepower answer to the LS3 in 2011 to a 500-horsepower Dark Horse in 2024, Ford's 5.0-liter Coyote V-8 is the ...
In its 2025 shareholder letter, Amazon ’s leadership reflected on the non-linear evolution of key businesses such as AWS and outlined how the company aims to navigate major technological and ...
Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results